Dr. Nduom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Department of Neurosurgery Emory University Atlanta, GA 30322
1365 Clifton Road NE Suite B6200
Atlanta, GA 30322Phone+1 404-778-5770
Summary
- Edjah K. Nduom, MD, FAANS, is the Daniel Louis Barrow Endowed Chair and Professor in the Department of Neurosurgery at Emory University School of Medicine. He serves as the Brain Tumor Disease Team Leader for Winship Cancer Institute. A fellowship-trained and board certified neurosurgical oncologist, Dr. Nduom's clinical specialty is the surgical management of brain and spinal cord tumors. He is particularly interested in the safe resection of malignant tumors located in eloquent areas of the brain, the brainstem and spinal cord. Dr. Nduom is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University. He holds numerous positions in national and international medical societies. Notably, he is Co-Founder and Diasporan Representative of the Society for Neuro-Oncology Sub-Saharan Africa; International Outreach Committee Co-Chair of the Society for Neuro-Oncology; Membership Director of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and Member of the Board of Directors of the National Brain Tumor Society. Dr. Nduom received his MD from University of Pennsylvania in Philadelphia, Pennsylvania. He completed a residency in Neurosurgery at Emory University in Atlanta, Georgia. He completed a Research Fellowship in Neurosurgical Oncology in the Surgical Neurology Branch of the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, and an additional Neurosurgical Oncology Fellowship at MD Anderson Cancer Center in Houston, Texas. Dr. Nduom's research focuses on the modulation of the immune system for the treatment of malignant brain tumors. He has presented his translational and clinical work on immune therapy for brain tumors at numerous national and international meetings.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2013 - 2015
- Emory University School of MedicineResidency, Neurological Surgery, 2006 - 2013
- Clinical Center at the National Institutes of HealthFellowship, Neurosurgical Oncology, 2011 - 2012
- Perelman School of Medicine at the University of PennsylvaniaClass of 2006
- Stanford UniversityB.S., Biomechanical Engineering, 2002
Certifications & Licensure
- GA State Medical License 2020 - 2025
- NC State Medical License 2020 - 2022
- TX State Medical License 2014 - 2022
- VA State Medical License 2019 - 2022
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Fourth Place Overall AANS Neurosurgical Ventriculostomy Top Gun Competition, 2010
- Hovies Fund Scholarship University of Pennsylvania, 2002
- UPenn Joel Gordon Miller Award for graduating seniors University of Pennsylvania
- Join now to see all
Clinical Trials
- Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade Start of enrollment: 2018 Sep 24
Publications & Presentations
PubMed
- 26 citationsCytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint BlockadeJohn Lynes, Sadhana Jackson, Victoria Sanchez, Gifty Dominah, Xiang Wang
Neurosurgery. 2019-04-01 - 253 citationsImmunosuppressive mechanisms in glioblastomaEdjah K. Nduom, Michael Weller, Amy B. Heimberger
Neuro-Oncology. 2015-11-01 - 38 citationsDistinct phenotypic states and spatial distribution of CD8T cell clonotypes in human brain metastases.Lisa J Sudmeier, Kimberly B Hoang, Edjah K Nduom, Andreas Wieland, Stewart G Neill
Cell Reports. Medicine. 2022-05-17
Journal Articles
- Clinical Decision Making in the Era of Immunotherapy for High Grade-Glioma: Report of Four CasesMartha Quezado, Brett J Theeler, Deric M Park, Edjah Nduom, Nancy Garren, Surabhi Ranjan, Kareem A Zaghloul, BioMed Central
- miR-142-3p Inhibits the M2 Macrophage and Exerts Therapeutic Efficacy Against Murine GlioblastomaXu S, Wei J, Wang F, Kong LY, Ling XY, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB, J Natl Cancer Inst, 1/28/2014
- Comparison of Pulsed and Continuous Convective Flow for Central Nervous System InfusionWalbridge S, Lonser RR, J Neurosurg, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Study of the Relationship Between Glial Processes and the Vasculature in Enhancing and Non-enhaning Malignant Lesions of the BrainYang C, Merrill MJ, Zhuang Z, Lonser RR, Congress of Neurological Surgeons Annual Meeting, 1/1/2012
- Comparison of Pulsed versus Continuous Convective Flow for Central Nervous System Tissue PerfusionWalbridge S, Lonser RR, Congress of Neurological Surgeons Annual Meeting, 1/1/2012
- Burr Hole Neurosurgery: Neuroendoscopic Resection of Intraventricular Tumors and Cysts Through a Working ChannelHill K, Chhabra V, Hadjipanayis CG, American Association of Neurological Surgeons Annual Meeting, 1/1/2012
- Join now to see all
Lectures
- Brain Tumor Immunology and ImmunotherapyDepartment of Neurosurgery, Baylor College of Medicine, Houston TX (2014); Houston TX (2015); The MD - 1/1/2015
- Immunotherapy and Gene Therapy for Brain TumorsHospital Sirio Libanes, Sao Paulo (2014, 2015) - 1/1/2015
- Immune Modulating MicroRNAs: A Novel Gene Therapeutic Platform for GlioblastomaDepartment of Neurosurgery, Emory University, Atlanta, GA - 1/1/2015
- Join now to see all
Press Mentions
- Glioblastoma Is the Best Known Brain Cancer, but It Is RareMay 2nd, 2022
- From Cleaner to Neurosurgeon at Vanderbilt University Medical Center – Dr Kwadwo Sarpong’s StoryMarch 21st, 2022
- Local Neurosurgeon Joins President Biden in Effort to Reduce Cancer Deaths by 50%February 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: